Pharmaceutical Executive April 17, 2024
In an interview with Pharm Exec Associate Editor Don Tracy, Lene Oddershede, SVP, Natural & Technical Sciences, Novo Nordisk Foundation discusses a recent grant awarded to the Copenhagen Center for Biomedical Quantum Sensing.
PE: Regarding the grant awarded to the Copenhagen Center for Biomedical Quantum Sensing, what was the impetus for the Novo Nordisk Foundation to investigate quantum sensing?
Oddershede: The foundation has had a strategy for the last three years to enable the development of quantum technologies in order to solve real problems in life sciences and the pharmaceutical side. The reason we invest in this is because quantum sensing is probably the technology that is closest to having real clinical translational impact. Among all the different technologies which...
Today's Sponsors
Today's Sponsor